AR

Avancha Rajeshwar

Active Director Director DIN 06942669
DIN 06942669 First appointment Aug 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Aug 2014
Shareholding value •••• Premium profile

About Avancha Rajeshwar

Data last updated:

Avancha Rajeshwar is a Director at Shrestha Sunrise Hospitals Private Limited (since 2025), Director at Trinity Minechem Private Limited (since 2014) and Designated Partner at Surgeye Llp (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Metals and Minerals and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9.78 Cr; the largest is Shrestha Sunrise Hospitals Private Limited at ₹9.38 Cr (FY 2025). Earlier, Avancha Rajeshwar was a Designated Partner at Apollo Property Developers Llp (2019–2021) and Designated Partner at Rapha Health (India) Llp (from 2019).

DIN 06942669
Primary Designation Director
Industry Healthcare
First Appointment 07 Aug 2014
Oldest Company Age 12 yrs
Largest company Shrestha Sunrise Hospitals Private Limited · ₹9.38 Cr (FY 2025)
Combined revenue ₹9.78 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Mar 20252021₹9.38 Cr (FY 2025)Active
Trinity Minechem Private Limited U14200TG2014PTC095156
Director07 Aug 20142014₹39.7 Lakh (FY 2019)Active
Surgeye Llp ACM-9582
Designated Partner22 Mar 20252025Active
Rapha Health (India) Private Limited U85190TG2020PTC138113
Director01 Jan 20202020Active
Director18 Nov 20192018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Oct 20192019Active
Designated Partner31 Oct 20192018Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trinity Minechem Private Limited
Indgene Biologics India Private Limited
Rapha Health (India) Private Limited
Rapha Health (India) Llp
Premium access

Shareholding and investment profile for Avancha Rajeshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avancha Rajeshwar

Avancha Rajeshwar currently holds 5 directorships: Shrestha Sunrise Hospitals Private Limited (Director, since 12 Mar 2025, revenue ₹9.38 Cr (FY 2025)); Trinity Minechem Private Limited (Director, since 07 Aug 2014, revenue ₹39.7 Lakh (FY 2019)); Surgeye Llp (Designated Partner, since 22 Mar 2025); Rapha Health (India) Private Limited (Director, since 01 Jan 2020); Indgene Biologics India Private Limited (Director, since 18 Nov 2019).

Avancha Rajeshwar was first appointed on 07 Aug 2014 as Director at Trinity Minechem Private Limited. The most recent appointment on record is 22 Mar 2025 at Surgeye Llp.

The 2 current companies of Avancha Rajeshwar that report revenue have a combined latest revenue of ₹9.78 Cr: Shrestha Sunrise Hospitals Private Limited ₹9.38 Cr (FY 2025); Trinity Minechem Private Limited ₹39.7 Lakh (FY 2019).

Avancha Rajeshwar held 2 earlier board appointments: Apollo Property Developers Llp (Designated Partner, 16 Oct 2019 to 05 Feb 2021); Rapha Health (India) Llp (Designated Partner, from 31 Oct 2019).

The current boards of Avancha Rajeshwar's companies include Ravi Suman (Shrestha Sunrise Hospitals Private Limited), Shankar Mittapalli (Shrestha Sunrise Hospitals Private Limited), Vithya (Shrestha Sunrise Hospitals Private Limited), Challa Srinivas Reddy (Trinity Minechem Private Limited), Maroju Suguna (Trinity Minechem Private Limited), Surya Prakash Pendyala (Trinity Minechem Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available